SCHEMBL25826242

SCHEMBL25826242

COC(=O)c1ccc(Nc2ccnc3ccc([N+](=O)[O-])cc23)nc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.54
KMT2A Q03164 5/20 0.54
USP2 O75604 2/20 0.54
KDM4E B2RXH2 2/20 0.46
ALDH1A1 P00352 2/20 0.46
POLB P06746 2/20 0.46
THRB P10828 1/20 0.46
MAPK1 P28482 1/20 0.46
MCL1 Q07820 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
CCNC P24863 1/20 0.45
CDK8 P49336 1/20 0.45
PKM P14618 2/20 0.44
MEN1 O00255 3/20 0.44
RECQL P46063 1/20 0.44
HTT P42858 2/20 0.43
GAA P10253 1/20 0.41
NCOA1 Q15788 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25826240 0.88 KMT2A (0.57) MAPTKMT2AUSP2KDM4EALDH1A1
SCHEMBL23999795 0.84 RET (0.43) MAPTKMT2AKDM4EALDH1A1MAPK1
SCHEMBL23999501 0.81 HCAR3 (0.48) MAPTKDM4EALDH1A1MAPK1TDP1
SCHEMBL23999539 0.81 MAPK1 (0.47) MAPTKMT2AKDM4EALDH1A1MAPK1
SCHEMBL23999976 0.80 GAK (0.53) CCNCCDK8DYRK3CDK1GSK3B
SCHEMBL19151335 0.80 MAPT (0.82) MAPTKMT2AUSP2KDM4EALDH1A1
SCHEMBL30180657 0.80 MAPT (0.82) MAPTKMT2AUSP2KDM4EALDH1A1
SCHEMBL25825372 0.80 KMT2A (0.70) MAPTKMT2AUSP2KDM4EALDH1A1
SCHEMBL25826247 0.79 MAPT (0.56) MAPTKMT2AUSP2KDM4EALDH1A1
SCHEMBL23999853 0.78 NPC1 (0.43) MAPTKMT2ANPC1RAB9ACDK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230183226-A1 AKT3 MODULATORS Georgiamune Inc. 2023-06-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230183226-A1 AKT3 MODULATORS AKT3, AKT2, MTOR MAPT 3999/4885KMT2A 3974/4885USP2 3935/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.